Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
See Latest ArticlesPrognostic significance of peritoneal tumour cells identified at surgery for colorectal cancer
British Journal of Surgery, 06/24/09
Katoh H et al. - In a trial to determine whether detection of intraperitoneal tumour cells (IPCs) could be used as a prognostic marker for selecting pts at high risk of recurrence, it appears that IPCs were associated with haematogenous recurrence rather than peritoneal or local recurrence in pts with stage III disease. The presence of IPCs is a significant prognostic factor in pts with stage III colorectal cancer (CRC).
Methods- The study included 226 pts with CRC who underwent elective resection.
- Clinical variables, including the presence of IPCs, were analysed for their prognostic significance.
- 33 pts (14.6%) were positive for IPCs.
- Univariable analysis indicated that the presence of IPCs was a significant prognostic factor in pts with stage III CRC; 5-yr disease-specific survival rate was 14% in IPC-positive pts vs 79% in those without IPCs.
- Multivariable analysis showed that IPC positivity was the most robust prognostic factor in stage III disease, whereas nodal category (N1 or N2) showed no significant association with prognosis.
- IPCs were associated with haematogenous recurrence rather than peritoneal or local recurrence in pts with stage III disease.
Today in Colo-Rectal...keeping you current
Receive free subspecialty "5-minute updates" via email
Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Surgical management of colorectal liver metastases
Community Oncology , 10/09/09
Localized resection for colon cancer
Surgical Oncology, 11/04/09
Today in Surgical Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Original contribution: surgeon recommendations and receipt of mastectomy for treatment of breast cancer
JAMA, 10/28/09
Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis : The Lancet Oncology
The Lancet Oncology - Online First, 10/23/09
Surgical management of colorectal liver metastases
Community Oncology , 10/09/09
Sponsor
Article Search
Sponsor